Journal
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
Volume 772, Issue -, Pages 13-22Publisher
ELSEVIER
DOI: 10.1016/j.mrrev.2016.09.004
Keywords
HPV binding entry intracellular trafficking
Funding
- American Cancer Society [RSG-12-021-01-MPC]
- National Cancer Institute, National Institute of Health [R21CA153096]
Ask authors/readers for more resources
Human papillomavirus (HPV) is a sexually transmitted virus responsible for the development of cervical cancer, anal cancer, head and throat cancers, as well as genital area warts. A major focus of current HPV research is on preventing the virus from entering a cell and transferring its genetic material to the nucleus, thus potentially preventing the development of cancer. Although the available HPV vaccines are extremely successful, approximately 15 additional cancer-causing HPVs have been identified that the vaccines do not protect against. Therefore, roughly 150,000 cancer cases will not be prevented annually with the current vaccines. Research efforts focused on the basic cell biology of HPV infection have a goal of identifying common infectious events that may lead to inexpensive vaccines or anti-virals to prevent infection by most, if not all, HPVs. In this review we attempt to summarize what is known regarding the process of HPV binding, entry, and intracellular trafficking. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available